STOCKWATCH
·
Major Chemicals
Quarterly ResultMay 6, 2026, 04:39 PM

Albemarle Q1 Net Sales +32.7% to $1.43B; EPS $2.35; Divests Refining Unit

AI Summary

Albemarle Corporation reported significantly improved financial results for Q1 2026, with net sales increasing by 32.7% to $1.43 billion and diluted EPS turning positive to $2.34 from a loss in the prior year. The company completed the divestment of its controlling interest in the Refining Solutions business for $525.2 million cash, incurring a $95.0 million loss, and also sold its Eurecat S.A. interest for $123 million, realizing a $42.3 million gain. These proceeds were largely used to repay $1.3 billion in long-term debt, resulting in a $12.6 million gain on early extinguishment. Additionally, Albemarle recorded $24.7 million in restructuring charges related to placing Kemerton Train 1 into care and maintenance.

Key Highlights

  • Divested controlling interest in Refining Solutions business for $525.2M cash.
  • Recorded $95.0M loss on sale of Refining Solutions business.
  • Sold 50% interest in Eurecat S.A. for $123M, realizing $42.3M gain.
  • Repaid $1.3B in long-term debt, generating $12.6M gain.
  • Q1 2026 Net Sales increased 32.7% to $1.43B.
  • Q1 2026 Diluted EPS was $2.34, up from $(0.00).
  • Q1 2026 Net Income attributable to Albemarle was $319.1M.
  • Incurred $24.7M restructuring charges for Kemerton Train 1.
  • Declared quarterly cash dividend of $0.405 per share.
ALB
Major Chemicals
ALBEMARLE CORP

Price Impact